3.24.1.u1 html 290 287 1 false 102 0 false 11 false false R1.htm 0000001 - Document - Cover Sheet http://royaltypharma.com/role/Cover Cover Cover 1 false false R2.htm 0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://royaltypharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://royaltypharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://royaltypharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS??? EQUITY Sheet http://royaltypharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS??? EQUITY Statements 5 false false R6.htm 0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS??? EQUITY (Parenthetical) Sheet http://royaltypharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYParenthetical CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS??? EQUITY (Parenthetical) Statements 6 false false R7.htm 0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://royaltypharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 7 false false R8.htm 0000008 - Disclosure - Organization and Purpose Sheet http://royaltypharma.com/role/OrganizationandPurpose Organization and Purpose Notes 8 false false R9.htm 0000009 - Disclosure - Summary of Significant Accounting Policies Sheet http://royaltypharma.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 0000010 - Disclosure - Available for Sale Debt Securities Sheet http://royaltypharma.com/role/AvailableforSaleDebtSecurities Available for Sale Debt Securities Notes 10 false false R11.htm 0000011 - Disclosure - Fair Value Measurements and Financial Instruments Sheet http://royaltypharma.com/role/FairValueMeasurementsandFinancialInstruments Fair Value Measurements and Financial Instruments Notes 11 false false R12.htm 0000012 - Disclosure - Financial Royalty Assets Sheet http://royaltypharma.com/role/FinancialRoyaltyAssets Financial Royalty Assets Notes 12 false false R13.htm 0000013 - Disclosure - Cumulative Allowance and the Provision for Changes in Expected Cash Flows from Financial Royalty Assets Sheet http://royaltypharma.com/role/CumulativeAllowanceandtheProvisionforChangesinExpectedCashFlowsfromFinancialRoyaltyAssets Cumulative Allowance and the Provision for Changes in Expected Cash Flows from Financial Royalty Assets Notes 13 false false R14.htm 0000014 - Disclosure - Non-Consolidated Affiliates Sheet http://royaltypharma.com/role/NonConsolidatedAffiliates Non-Consolidated Affiliates Notes 14 false false R15.htm 0000015 - Disclosure - Research and Development (R&D) Funding Expense Sheet http://royaltypharma.com/role/ResearchandDevelopmentRDFundingExpense Research and Development (R&D) Funding Expense Notes 15 false false R16.htm 0000016 - Disclosure - Borrowings Sheet http://royaltypharma.com/role/Borrowings Borrowings Notes 16 false false R17.htm 0000017 - Disclosure - Shareholders' Equity Sheet http://royaltypharma.com/role/ShareholdersEquity Shareholders' Equity Notes 17 false false R18.htm 0000018 - Disclosure - Earnings per Share Sheet http://royaltypharma.com/role/EarningsperShare Earnings per Share Notes 18 false false R19.htm 0000019 - Disclosure - Indirect Cash Flow Sheet http://royaltypharma.com/role/IndirectCashFlow Indirect Cash Flow Notes 19 false false R20.htm 0000020 - Disclosure - Commitments and Contingencies Sheet http://royaltypharma.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 20 false false R21.htm 0000021 - Disclosure - Related Party Transactions Sheet http://royaltypharma.com/role/RelatedPartyTransactions Related Party Transactions Notes 21 false false R22.htm 0000022 - Disclosure - Subsequent Events Sheet http://royaltypharma.com/role/SubsequentEvents Subsequent Events Notes 22 false false R23.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 23 false false R24.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 24 false false R25.htm 9954471 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://royaltypharma.com/role/SummaryofSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://royaltypharma.com/role/SummaryofSignificantAccountingPolicies 25 false false R26.htm 9954472 - Disclosure - Available for Sale Debt Securities (Tables) Sheet http://royaltypharma.com/role/AvailableforSaleDebtSecuritiesTables Available for Sale Debt Securities (Tables) Tables http://royaltypharma.com/role/AvailableforSaleDebtSecurities 26 false false R27.htm 9954473 - Disclosure - Fair Value Measurements and Financial Instruments (Tables) Sheet http://royaltypharma.com/role/FairValueMeasurementsandFinancialInstrumentsTables Fair Value Measurements and Financial Instruments (Tables) Tables http://royaltypharma.com/role/FairValueMeasurementsandFinancialInstruments 27 false false R28.htm 9954474 - Disclosure - Financial Royalty Assets (Tables) Sheet http://royaltypharma.com/role/FinancialRoyaltyAssetsTables Financial Royalty Assets (Tables) Tables http://royaltypharma.com/role/FinancialRoyaltyAssets 28 false false R29.htm 9954475 - Disclosure - Cumulative Allowance and the Provision for Changes in Expected Cash Flows from Financial Royalty Assets (Tables) Sheet http://royaltypharma.com/role/CumulativeAllowanceandtheProvisionforChangesinExpectedCashFlowsfromFinancialRoyaltyAssetsTables Cumulative Allowance and the Provision for Changes in Expected Cash Flows from Financial Royalty Assets (Tables) Tables http://royaltypharma.com/role/CumulativeAllowanceandtheProvisionforChangesinExpectedCashFlowsfromFinancialRoyaltyAssets 29 false false R30.htm 9954476 - Disclosure - Borrowings (Tables) Sheet http://royaltypharma.com/role/BorrowingsTables Borrowings (Tables) Tables http://royaltypharma.com/role/Borrowings 30 false false R31.htm 9954477 - Disclosure - Shareholders' Equity (Tables) Sheet http://royaltypharma.com/role/ShareholdersEquityTables Shareholders' Equity (Tables) Tables http://royaltypharma.com/role/ShareholdersEquity 31 false false R32.htm 9954478 - Disclosure - Earnings per Share (Tables) Sheet http://royaltypharma.com/role/EarningsperShareTables Earnings per Share (Tables) Tables http://royaltypharma.com/role/EarningsperShare 32 false false R33.htm 9954479 - Disclosure - Indirect Cash Flow (Tables) Sheet http://royaltypharma.com/role/IndirectCashFlowTables Indirect Cash Flow (Tables) Tables http://royaltypharma.com/role/IndirectCashFlow 33 false false R34.htm 9954480 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://royaltypharma.com/role/SummaryofSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://royaltypharma.com/role/SummaryofSignificantAccountingPoliciesPolicies 34 false false R35.htm 9954481 - Disclosure - Available for Sale Debt Securities - Narrative (Details) Sheet http://royaltypharma.com/role/AvailableforSaleDebtSecuritiesNarrativeDetails Available for Sale Debt Securities - Narrative (Details) Details 35 false false R36.htm 9954482 - Disclosure - Available for Sale Debt Securities - Summary of Available for Sale Debt Securities (Details) Sheet http://royaltypharma.com/role/AvailableforSaleDebtSecuritiesSummaryofAvailableforSaleDebtSecuritiesDetails Available for Sale Debt Securities - Summary of Available for Sale Debt Securities (Details) Details 36 false false R37.htm 9954483 - Disclosure - Fair Value Measurements and Financial Instruments - Summary of Fair Value Hierarchy (Details) Sheet http://royaltypharma.com/role/FairValueMeasurementsandFinancialInstrumentsSummaryofFairValueHierarchyDetails Fair Value Measurements and Financial Instruments - Summary of Fair Value Hierarchy (Details) Details 37 false false R38.htm 9954484 - Disclosure - Fair Value Measurements and Financial Instruments - Narrative (Details) Sheet http://royaltypharma.com/role/FairValueMeasurementsandFinancialInstrumentsNarrativeDetails Fair Value Measurements and Financial Instruments - Narrative (Details) Details http://royaltypharma.com/role/FairValueMeasurementsandFinancialInstrumentsTables 38 false false R39.htm 9954485 - Disclosure - Fair Value Measurements and Financial Instruments - Summary of Change in Carrying Value of Level 3 Financial Instruments (Details) Sheet http://royaltypharma.com/role/FairValueMeasurementsandFinancialInstrumentsSummaryofChangeinCarryingValueofLevel3FinancialInstrumentsDetails Fair Value Measurements and Financial Instruments - Summary of Change in Carrying Value of Level 3 Financial Instruments (Details) Details 39 false false R40.htm 9954486 - Disclosure - Fair Value Measurements and Financial Instruments - Summary of Estimated Fair Values Based on Level 3 Inputs (Details) Sheet http://royaltypharma.com/role/FairValueMeasurementsandFinancialInstrumentsSummaryofEstimatedFairValuesBasedonLevel3InputsDetails Fair Value Measurements and Financial Instruments - Summary of Estimated Fair Values Based on Level 3 Inputs (Details) Details 40 false false R41.htm 9954487 - Disclosure - Financial Royalty Assets - Summary of Financial Royalty Assets, Net (Details) Sheet http://royaltypharma.com/role/FinancialRoyaltyAssetsSummaryofFinancialRoyaltyAssetsNetDetails Financial Royalty Assets - Summary of Financial Royalty Assets, Net (Details) Details 41 false false R42.htm 9954488 - Disclosure - Financial Royalty Assets - Narrative (Details) Sheet http://royaltypharma.com/role/FinancialRoyaltyAssetsNarrativeDetails Financial Royalty Assets - Narrative (Details) Details 42 false false R43.htm 9954489 - Disclosure - Cumulative Allowance and the Provision for Changes in Expected Cash Flows from Financial Royalty Assets (Details) Sheet http://royaltypharma.com/role/CumulativeAllowanceandtheProvisionforChangesinExpectedCashFlowsfromFinancialRoyaltyAssetsDetails Cumulative Allowance and the Provision for Changes in Expected Cash Flows from Financial Royalty Assets (Details) Details http://royaltypharma.com/role/CumulativeAllowanceandtheProvisionforChangesinExpectedCashFlowsfromFinancialRoyaltyAssetsTables 43 false false R44.htm 9954490 - Disclosure - Non-Consolidated Affiliates (Details) Sheet http://royaltypharma.com/role/NonConsolidatedAffiliatesDetails Non-Consolidated Affiliates (Details) Details http://royaltypharma.com/role/NonConsolidatedAffiliates 44 false false R45.htm 9954491 - Disclosure - Research and Development (R&D) Funding Expense (Details) Sheet http://royaltypharma.com/role/ResearchandDevelopmentRDFundingExpenseDetails Research and Development (R&D) Funding Expense (Details) Details http://royaltypharma.com/role/ResearchandDevelopmentRDFundingExpense 45 false false R46.htm 9954492 - Disclosure - Borrowings - Summary of Borrowings (Details) Sheet http://royaltypharma.com/role/BorrowingsSummaryofBorrowingsDetails Borrowings - Summary of Borrowings (Details) Details 46 false false R47.htm 9954493 - Disclosure - Borrowings - Narrative (Details) Sheet http://royaltypharma.com/role/BorrowingsNarrativeDetails Borrowings - Narrative (Details) Details 47 false false R48.htm 9954494 - Disclosure - Borrowings - Summary of Repayments of Debt by Year (Details) Sheet http://royaltypharma.com/role/BorrowingsSummaryofRepaymentsofDebtbyYearDetails Borrowings - Summary of Repayments of Debt by Year (Details) Details 48 false false R49.htm 9954495 - Disclosure - Shareholders' Equity - Narrative (Details) Sheet http://royaltypharma.com/role/ShareholdersEquityNarrativeDetails Shareholders' Equity - Narrative (Details) Details 49 false false R50.htm 9954496 - Disclosure - Shareholders' Equity - Summary of Noncontrolling Interests (Details) Sheet http://royaltypharma.com/role/ShareholdersEquitySummaryofNoncontrollingInterestsDetails Shareholders' Equity - Summary of Noncontrolling Interests (Details) Details 50 false false R51.htm 9954497 - Disclosure - Earnings per Share (Details) Sheet http://royaltypharma.com/role/EarningsperShareDetails Earnings per Share (Details) Details http://royaltypharma.com/role/EarningsperShareTables 51 false false R52.htm 9954498 - Disclosure - Indirect Cash Flow (Details) Sheet http://royaltypharma.com/role/IndirectCashFlowDetails Indirect Cash Flow (Details) Details http://royaltypharma.com/role/IndirectCashFlowTables 52 false false R53.htm 9954499 - Disclosure - Commitments and Contingencies (Details) Sheet http://royaltypharma.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://royaltypharma.com/role/CommitmentsandContingencies 53 false false R54.htm 9954500 - Disclosure - Related Party Transactions (Details) Sheet http://royaltypharma.com/role/RelatedPartyTransactionsDetails Related Party Transactions (Details) Details http://royaltypharma.com/role/RelatedPartyTransactions 54 false false R55.htm 9954501 - Disclosure - Subsequent Events (Details) Sheet http://royaltypharma.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://royaltypharma.com/role/SubsequentEvents 55 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: ecd:TrdArrDuration - rprx-20240331.htm 4 rprx-20240331.htm rprx-20240331.xsd rprx-20240331_cal.xml rprx-20240331_def.xml rprx-20240331_lab.xml rprx-20240331_pre.xml http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true